Division of Nephrology and Hypertension, and Nephrology Clinical Trials Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Med Clin North Am. 2013 Jan;97(1):53-8. doi: 10.1016/j.mcna.2012.10.006. Epub 2012 Nov 27.
Diabetic nephropathy (DN) refers to the structural and functional changes in the kidneys of patients with diabetes mellitus (type 1 or 2). A subset of patients with presumed DN may not have overt proteinuria as a prerequisite to renal failure, contrary to the classical paradigm. No animal model fully recapitulates the human subset. All studies on this subject are observational and most lack biopsy data. Many mechanisms have been postulated, including use of renin-angiotensin system agents, recurrent bouts of acute kidney injury, genetic predisposition, and renal lesions other than DN. A well-designed biopsy study and a series of intervention trials are needed to fully understand this entity.
糖尿病肾病(DN)是指糖尿病患者(1 型或 2 型)肾脏的结构和功能变化。与经典模式相反,一些推测患有 DN 的患者可能没有明显的蛋白尿作为肾衰竭的先决条件。没有任何动物模型能完全再现人类亚组。关于这个主题的所有研究都是观察性的,大多数缺乏活检数据。已经提出了许多机制,包括使用肾素-血管紧张素系统药物、反复发作的急性肾损伤、遗传易感性以及除 DN 以外的肾脏病变。需要进行精心设计的活检研究和一系列干预试验,以充分了解这一实体。